Martha Demski Biography and Net Worth

Ms. Demski has more than 30 years of experience in the fields of finance and biotechnology. She is chair of the board of directors of Chimerix, where she also serves as a member of the audit committee. She also chairs the audit committee and serves on the compensation committee at ADMA Biologics and Equillium. Previously, Ms. Demski served as Senior Vice President and Chief Financial Officer of Ajinomoto Althea, Inc., as well as interim Chief Operating Officer and Chief Financial Officer of the Sidney Kimmel Cancer Center. She has also served as Chief Financial Officer of Vical Incorporated, where she was responsible for multiple private and public financings, including the company’s initial public offering. Additionally, Ms. Demski also has more than 13 years of banking experience with Bank of America. She holds an MBA from The University of Chicago Booth School of Business and a BA from Michigan State University. In 2014 Ms. Demski was awarded the CFO of the Year Award of Distinction by the San Diego Business Journal. In 2017 Ms. Demski was honored as the Director of the Year in Corporate Governance by the San Diego Corporate Directors Forum.